Suchergebnisse - "Scribano, Maria Lia"

PubPharm (17)

1

Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?

enthalten in: Digestive diseases and sciences | 2020

von Scribano, M.

2

Safety of treatments for inflammatory bowel disease: clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease | 2017

von Biancone, L. | Annese, V. | Ardizzone, S. | +25

3

Randomised controlled trial of mesalazine in IBS

enthalten in: Gut | 2016

von Basilisco, G. | Cremon, C. | Rodi, M. | +19

4

Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]

enthalten in: Digestive and liver disease | 2016

von Armuzzi, A. | Gionchetti, P. | Daperno, M. | +13

5

Budesonide multi-matrix system formulation for treating ulcerative colitis

enthalten in: Expert opinion on pharmacotherapy | 2014

von Prantera, C. | Scribano, M.

6

Mo1264 Clinical Characteristics of Inflammatory Bowel Disease May Influence the Cancer Risk When Using Immunomodulators: Incident Cases of Cancer in a Multicenter Case-Control Study

enthalten in: Gastroenterology | 2013

von Petrruzziello, C. | Armuzzi, A. | Kohn, A. | +18

7

Sa1270 Early Post-Operative Endoscopic Recurrence in Crohns Disease Patients: Data From a Large Prospective Italian Multicenter Cohort

enthalten in: Gastroenterology | 2012

von Orlando, A. | Mocciaro, F. | Scimeca, D. | +21

8

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

enthalten in: Gastroenterology | 2012

von Prantera, C. | Lochs, H. | Grimaldi, M. | +3

9

W1245 Successful Induction of Clinical Response and Remission with Certolizumab Pegol in Crohns Disease Patients Who Are Primary Non-Responders or Intolerant to Infliximab: A Real Life Multi-Center Experience of Compassionate Use

enthalten in: Gastroenterology | 2008

von Danese, S. | Mocciaro, F. | Guidi, L. | +9

10

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: A real-life multicenter experience of compassionate use

enthalten in: Inflammatory bowel diseases | 2008

von Danese, S. | Mocciaro, F. | Guidi, L. | +13